文献速递临床试验与 GCP流行病学与生物统计

加强基层医疗识别与治疗抑郁(SPiRiT-D):协作医疗模式整群随机实效-实施试验研究方案

Strengthening Primary Care for Recognising and Treating Depression (SPiRiT-D): a study protocol for a cluster randomised controlled effectiveness-implementation trial of collaborative care for depression.
PubMed 文献 · Trials · 2026-01-28

该方案拟在巴基斯坦卡拉奇社会经济弱势地区24家基层诊所开展II型实效-实施整群随机对照试验,按1:1最小化随机分配至情境适配协作医疗模式(联合共同设计实施策略)或优化常规照护;纳入年龄≥18岁、PHQ-9评分≥10且未接受积极抗抑郁治疗者,主要临床结局为招募后6个月PHQ-9抑郁严重度,主要实施结局为6个月时诊所层面“覆盖”比例,并行过程与经济评价。

要点

  • 在巴基斯坦卡拉奇24家基层诊所开展整群随机实效-实施试验,比较协作医疗与优化常规照护。
  • 纳入年龄≥18岁、PHQ-9评分≥10且未接受积极抗抑郁治疗者。
  • 主要临床结局为招募后6个月PHQ-9抑郁严重度,主要实施结局为6个月时诊所层面“覆盖”比例。

核心结论

  • 若协作医疗被成功实施且具有临床与成本效果,将为基层就诊的抑郁患者带来健康与经济获益,并有助于通过受训 workforce 识别和管理抑郁、改善信息管理系统和促进循证照护来加强基层医疗服务。

研究设计与样本

  • II型实效-实施整群随机对照试验,嵌入过程评价与经济评价,在巴基斯坦卡拉奇社会经济弱势地区24家基层诊所按1:1最小化随机分配至情境适配协作医疗模式联合共同设计实施策略组或优化常规照护组。
  • 纳入年龄≥18岁、9项患者健康问卷(PHQ-9)评分≥10且未接受任何积极抗抑郁治疗者。
  • 采用Reach、Effectiveness、Adoption、Implementation and Maintenance框架指导结局评价;过程评价采用混合方法并依据Consolidated Framework for Implementation Research探索保真度、可接受性和可持续性等;试验内经济评价探索协作医疗与实施活动的成本效果;个体层面实效结局采用混合效应线性回归分析,诊所层面实施结局采用广义线性回归分析,按意向性治疗原则分析。

主要发现

  • 主要临床结局为招募后6个月时采用PHQ-9评估的抑郁严重度。
  • 主要实施结局为6个月时基于常规诊所层面汇总数据计算的“覆盖”比例,即参与抑郁治疗的人数除以符合该类治疗条件的人数。

关键数值与推荐

  • 纳入标准为年龄≥18岁且PHQ-9评分≥10、未接受任何积极抗抑郁治疗。
  • 优化常规照护组接受常规实践,并对筛查阳性者额外提供抑郁筛查和抑郁信息传单。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The effectiveness of collaborative care for treating depression in primary care has been well-established in high-income countries and, more recently, in a few trials in low- and middle-income countries (LMICs). However, evidence for its effectiveness, costs and how it can be implemented in 'real-world' settings within resource-constrained health systems in LMICs is currently limited. We aim to investigate the implementation, clinical and cost-effectiveness of a contextually adapted collaborative care model for depression in primary care clinics in Pakistan. METHODS: A hybrid type-II effectiveness-implementation cluster randomised controlled trial with embedded process and economic evaluations will be conducted. Twenty-four primary care clinics located in socioeconomically disadvantaged areas of Karachi will be randomly allocated (1:1) using minimisation to either (i) a contextually adapted collaborative care model for depression supported by co-designed implementation strategies or (ii) optimised usual care (routine practice with additional depression screening and provision of information leaflets about depression for those screening positive). Participants aged 18 years or above, scoring ≥ 10 on the 9-item Patient Health Questionnaire (PHQ-9) and not under any active treatment for depression, will be recruited. The Reach, Effectiveness, Adoption, Implementation and Maintenance framework will guide our outcome evaluation. The primary clinical outcome will be depression severity, assessed using the PHQ-9 at 6 months after participant recruitment. The primary implementation outcome will be 'reach' (proportion calculated as the number of people who participated in depression treatment divided by those eligible for such treatment) using routine, clinic-level aggregated data at 6 months. The process evaluation will explore factors such as fidelity, acceptability and sustainability of collaborative care using a mixed-methods approach guided by the Consolidated Framework for Implementation Research. A within-trial economic evaluation will explore the cost-effectiveness of both collaborative care and implementation activities. Individual-level effectiveness outcomes will be analysed using mixed-effect linear regression; and clinic-level implementation outcomes using generalised linear regression. Trial data analysis will be based on an intention to treat principle. DISCUSSION: If collaborative care is shown to be successfully implemented, clinically, and cost-effective, it will provide health and economic benefits for people with depression presenting in primary care. It will also be a means to strengthen primary care services through a trained workforce that can recognise and manage depression, improve information management systems, and promote evidence-based care. TRIAL REGISTRATION: ISRCTN13462277 prospectively registered on 07 October 2024 https://doi.org/10.1186/ISRCTN13462277 .

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Faisal MR, Bhatti MM, Walker S, et al. Strengthening Primary Care for Recognising and Treating Depression (SPiRiT-D): a study protocol for a cluster randomised controlled effectiveness-implementation trial of collaborative care for depression. Trials. 2026. PMID: 41606652. doi:10.1186/s13063-026-09453-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。